Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

AI and its potential impact on genomics research and clinical practice was peppered throughout this year's Festival of Genomics ...

Clinical trials for exa-cel have shown promising results that it has been authorised by the FDA and MHRA for use in beta thalassemia and sickle cell disease. These successes make CRISPR technology, as ...